Teva Pharmaceuticals USA, Inc.
Código de etiquetadora NDCs: 0093, 0172, 0480, 0555, 0575, 16252, 50111, 51759, 57844, 63459
¿Qué es una etiquetadora?
La empresa cuyo nombre aparece en el envase y en el directorio de códigos nacionales de medicamentos (NDC) de la FDA. Puede fabricar el medicamento o vender uno fabricado por otra empresa. La primera parte de cada código NDC identifica a la etiquetadora.
Solo datos oficiales de la FDA
Los productos, aprobaciones y retiros vienen de la FDA (directorio NDC, Drugs@FDA, informes de retiros). Los retiros se vinculan a esta empresa por el código NDC del producto retirado.
Si tiene preguntas sobre su medicamento, hable con su médico o farmacéutico. En una emergencia, llame al 911.
Medicamentos con receta
- Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfateAdderall, Adderall XR, Mixed Salts of a Single Entity Amphetamine Product XR · 14 productos
- Warfarin sodiumJantoven · 9 productos
- AmoxicillinAmoxil · 9 productos
- VenlafaxineEffexor XR · 8 productos
- ClonazepamKlonopin · 8 productos
- Dexmethylphenidate hydrochlorideFocalin XR, Focalin · 8 productos
- Glyburide8 productos
- Ustekinumab-aeknSelarsdi · 7 productos
- RisperidoneUzedy, Risperdal, Risperdal M-Tab · 7 productos
- AtomoxetineStrattera, Atoncy · 7 productos
- Fluticasone propionate and salmeterolFluticasone Propionate and Salmeterol Diskus, Advair Diskus, Advair HFA · 6 productos
- Cephalexin6 productos
- Hydroxyzine6 productos
- QuetiapineSeroquel, Seroquel XR · 6 productos
- Nefazodone hydrochloride5 productos
- Cyclobenzaprine hydrochlorideAmrix, Tonmya, Fexmid · 5 productos
- Amoxicillin and clavulanate potassium (amoxicillin / clavulanate)Augmentin, Augmentin Es-600 · 5 productos
- EstradiolEstradiol Vaginal, Dotti, Estradiol Transdermal System · 5 productos
- BuprenorphineBelbuca, Brixadi, Buprenorphine Transdermal System · 5 productos
- Olanzapine and fluoxetine5 productos
- AzithromycinZithromax, Azasite · 5 productos
- ClozapineClozaril, Versacloz · 5 productos
- BudesonidePulmicort Flexhaler, Pulmicort Respules, Uceris · 5 productos
- Olmesartan medoxomil / amlodipine besylate / hydrochlorothiazideTribenzor · 5 productos
- DiltiazemTiadylt ER, Cartia Xt, Cardizem La · 4 productos
- Penicillin v potassium4 productos
- Sunitinib malateSutent · 4 productos
- CyclosporineCyclosporine Modified, Cyclosporine, Modfied, Sandimmune · 4 productos
- TorsemideSoaanz · 4 productos
- BuspironeBucapsol · 4 productos
- Sotalol hydrochlorideSotalol Hydrochloride Af, Betapace Af, Betapace · 4 productos
- Hydralazine hydrochloride4 productos
- IsotretinoinZenatane, Absorica, Accutane · 4 productos
- CarvedilolCoreg, Coreg CR · 4 productos
- LansoprazolePrevacid Solutab, Prevacid · 4 productos
- OlanzapineZyprexa, Zyprexa Zydis, Olanzapine Intramuscular · 4 productos
- Vardenafil4 productos
- Nortriptyline hydrochloridePamelor · 4 productos
- DoxazosinCardura, Cardura XL · 4 productos
- Tolterodine tartrateDetrol · 4 productos
Mostrar los otros 115 medicamentos
- AtorvastatinLipitor · 4 productos
- Trazodone hydrochlorideRaldesy Tm · 4 productos
- Chlordiazepoxide hydrochloride3 productos
- Norethindrone acetate and ethinyl estradiolJunel 21 Day, Loestrin 21 Day, Fyavolv · 3 productos
- LevalbuterolXopenex HFA · 3 productos
- SildenafilViagra, Vybrique, Revatio · 3 productos
- FluvastatinLescol XL · 3 productos
- HydrochlorothiazideInzirqo · 3 productos
- FluoxetineProzac · 3 productos
- Medroxyprogesterone acetateProvera, Depo-Provera, Depo-Subq Provera · 3 productos
- Acitretin3 productos
- Liothyronine sodiumCytomel, Liomny · 3 productos
- ArmodafinilNuvigil · 3 productos
- Risedronate3 productos
- Prazosin hydrochloride3 productos
- Lanthanum carbonateFosrenol · 3 productos
- Losartan potassium and hydrochlorothiazideHyzaar · 3 productos
- Glipizide and metformin hydrochloride3 productos
- Mexiletine hydrochloride3 productos
- Lovastatin3 productos
- LorazepamAtivan, Loreev XR · 3 productos
- AtazanavirReyataz · 3 productos
- Erlotinib3 productos
- Famciclovir3 productos
- Cefdinir3 productos
- Etodolac3 productos
- PioglitazoneActos · 3 productos
- Cimetidine3 productos
- Fluocinonide3 productos
- AtenololTenormin · 3 productos
- Bisoprolol fumarate and hydrochlorothiazide3 productos
- Carbidopa and levodopaCrexont, Rytary, Sinemet · 3 productos
- DiazepamValium, Valtoco · 3 productos
- Danazol3 productos
- FamotidinePepcid · 2 productos
- DextroamphetamineZenzedi, Xelstrym, Dexedrine Spansule · 2 productos
- Dicloxacillin sodium2 productos
- Almotriptan2 productos
- EszopicloneLunesta · 2 productos
- ErythromycinEry, Ery-Tab · 2 productos
- MetronidazoleMetronidazole Vaginal, Likmez, Metronidazole Vaginal Gel · 2 productos
- Isoniazid2 productos
- Imatinib mesylateGleevec, Imkeldi · 2 productos
- MesalaminePentasa, Rowasa, Lialda · 2 productos
- Moexipril hydrochloride2 productos
- Cefprozil2 productos
- Isradipine2 productos
- Cilostazol2 productos
- Cefadroxil2 productos
- EpinephrineAuvi-Q, Adrenalin, Adrenalin (Epinephrine in Sodium Chloride) · 2 productos
- CalcitriolVectical · 2 productos
- Fremanezumab-vfrmAjovy · 2 productos
- MetoclopramideReglan, Gimoti · 2 productos
- RasagilineAzilect · 2 productos
- Disopyramide phosphateNorpace · 2 productos
- BaclofenLyvispah, Gablofen, Baclofen (Intrathecal) · 2 productos
- Irbesartan and hydrochlorothiazideAvalide · 2 productos
- Eletriptan hydrobromideRelpax · 2 productos
- Leucovorin calciumVykoura · 2 productos
- Piroxicam2 productos
- Megestrol acetate2 productos
- Rizatriptan benzoateRizafilm, Maxalt, Maxalt-Mlt · 2 productos
- CapecitabineXeloda · 2 productos
- LiraglutideVictoza, Saxenda · 1 producto
- Etonogestrel and ethinyl estradiolNuvaring, Eluryng, Enilloring · 1 producto
- DiflunisalDolobid · 1 producto
- Cromolyn sodiumGastrocrom · 1 producto
- Cefaclor1 producto
- CiprofloxacinCiprofloxacin in Dextrose, Cipro, Ciloxan · 1 producto
- Quinine sulfate1 producto
- Efavirenz, emtricitabine and tenofovir disoproxil fumarate1 producto
- KetoconazoleKetodan · 1 producto
- SulfasalazineAzulfidine, Azulfidine En-Tabs · 1 producto
- Tramadol hydrochlorideConzip · 1 producto
- Diclofenac epolamineLicart, Diclox Patch 30ct, Flector · 1 producto
- Formoterol fumaratePerforomist · 1 producto
- TobramycinBethkis, Tobramycin Inhalation Solution Pak, Tobi Podhaler · 1 producto
- Pravastatin sodium1 producto
- ClopidogrelPlavix · 1 producto
- Mycophenolate mofetilCellcept, Myhibbin · 1 producto
- AnastrozoleArimidex · 1 producto
- Emtricitabine and tenofovir disoproxil fumarateTruvada · 1 producto
- TioproninThiola Ec, Venxxiva, Thiola · 1 producto
- Oseltamivir phosphateTamiflu · 1 producto
- Doxepin hydrochlorideSilenor, Prudoxin, Zonalon · 1 producto
- OxybutyninOxytrol · 1 producto
- Neomycin sulfate1 producto
- IcatibantSajazir, Firazyr · 1 producto
- ImiquimodZyclara · 1 producto
- DiclofenacZipsor, Cambia, Lofena · 1 producto
- MupirocinPirnuo · 1 producto
- AcyclovirZovirax, Avaclyr · 1 producto
- Cabergoline1 producto
- Estradiol and norethindrone acetateLopreeza, Etyqa, Combipatch (Estradiol/Norethindrone Acetate Transdermal System) · 1 producto
- Mefloquine hydrochloride1 producto
- Amiloride hydrochloride and hydrochlorothiazide1 producto
- DiazoxideProglycem · 1 producto
- Ketorolac tromethamineAcular, Acuvail, Sprix · 1 producto
- NystatinNystop, Nyamyc, Klayesta · 1 producto
- SucralfateCarafate · 1 producto
- Hydroxychloroquine sulfatePlaquenil, Sovuna · 1 producto
- PenciclovirDenavir · 1 producto
- Raloxifene hydrochlorideEvista · 1 producto
- Levocetirizine dihydrochlorideXyzal · 1 producto
- Norethindrone and ethinyl estradiolNortrel 21 Day · 1 producto
- Eculizumab-aeebBkemv, Soliris, Epysqli · 1 producto
- Loperamide hydrochloride1 producto
- Teriparatide (teriparatide acetate)1 producto
- Albuterol sulfateVentolin HFA, Albuterol Sulate HFA, Proair Digihaler · 1 producto
- Methylergonovine maleateMethergine · 1 producto
- LetrozoleFemara · 1 producto
- Bendamustine hydrochlorideVivimusta, Treanda, Belrapzo · 1 producto
- Norethindrone acetateGallifrey · 1 producto
- MethotrexateRasuvo, Otrexup, Trexall · 1 producto
- HydroxyureaDroxia, Siklos, Hydrea · 1 producto
Solicitudes de la FDA de estos productos
- NDA: Solicitud de nuevo medicamento (NDA): así se aprueba un medicamento nuevo, normalmente de marca.
- ANDA: Solicitud abreviada (ANDA): así se aprueba una versión genérica.
- BLA: Solicitud de licencia de productos biológicos (BLA): así se aprueba un medicamento biológico (hecho a partir de células vivas).
| Aprobada | Solicitud | Medicamento | Patrocinador |
|---|---|---|---|
| 19 de julio de 2024 | BLA761340 | Eculizumab-aeeb EPYSQLI | Samsung Bioepis Co Ltd |
| 16 de abril de 2024 | BLA761343 | Ustekinumab-aekn SELARSDI | Alvotech USA Inc |
| 16 de noviembre de 2023 | ANDA208569 | Teriparatide (teriparatide acetate) TERIPARATIDE | Teva Pharms USA |
| 28 de abril de 2023 | NDA213586 | Risperidone UZEDY | Teva |
| 17 de febrero de 2023 | ANDA215408 | Doxepin hydrochloride DOXEPIN HYDROCHLORIDE | Teva Pharms |
| 9 de noviembre de 2022 | ANDA212710 | Penciclovir PENCICLOVIR | Teva Pharms USA |
| 27 de enero de 2022 | ANDA090977 | Lanthanum carbonate LANTHANUM CARBONATE | Barr |
| 13 de diciembre de 2021 | ANDA213948 | Fluticasone propionate and salmeterol FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE | Teva Pharms USA |
| 30 de noviembre de 2021 | ANDA213803 | Sunitinib malate SUNITINIB MALATE | Teva Pharms USA |
| 22 de junio de 2021 | ANDA091141 | Formoterol fumarate FORMOTEROL FUMARATE | Teva Pharms USA Inc |
| 26 de abril de 2021 | ANDA214326 | Tiopronin TIOPRONIN | Teva Pharms USA Inc |
| 11 de febrero de 2021 | ANDA214549 | Erythromycin ERYTHROMYCIN | Teva Pharms USA Inc |
| 13 de enero de 2021 | ANDA204305 | Etonogestrel and ethinyl estradiol ETHINYL ESTRADIOL; ETONOGESTREL | Teva Pharms USA Inc |
| 15 de julio de 2019 | ANDA210118 | Icatibant ICATIBANT ACETATE | Teva Pharms USA |
| 9 de mayo de 2019 | ANDA207873 | Mesalamine MESALAMINE | Teva Pharms USA |
| 20 de marzo de 2019 | ANDA211455 | Methylergonovine maleate METHYLERGONOVINE MALEATE | Teva Pharms USA |
| 27 de febrero de 2019 | ANDA211125 | Oseltamivir phosphate OSELTAMIVIR PHOSPHATE | Teva Pharms USA |
| 20 de noviembre de 2018 | ANDA204937 | Buprenorphine BUPRENORPHINE | Watson Labs Teva |
| 9 de noviembre de 2018 | ANDA091215 | Efavirenz, emtricitabine and tenofovir disoproxil fumarate EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE | Teva Pharms USA |
| 26 de octubre de 2018 | ANDA211510 | Liothyronine sodium LIOTHYRONINE SODIUM | Teva Pharms USA |
| 14 de septiembre de 2018 | BLA761089 | Fremanezumab-vfrm AJOVY | Teva Pharms USA |
| 16 de agosto de 2018 | ANDA090589 | Epinephrine EPINEPHRINE (AUTOINJECTOR) | Teva Pharms USA |
| 21 de septiembre de 2017 | ANDA208784 | Lansoprazole LANSOPRAZOLE | Teva Pharms USA |
| 21 de julio de 2017 | ANDA206388 | Estradiol ESTRADIOL | Teva Pharms USA |
| 27 de junio de 2017 | ANDA202040 | Eletriptan hydrobromide ELETRIPTAN HYDROBROMIDE | Teva Pharms USA |
Mostrar las otras 100 solicitudes
| Aprobada | Solicitud | Medicamento | Patrocinador |
|---|---|---|---|
| 8 de junio de 2017 | ANDA090894 | Emtricitabine and tenofovir disoproxil fumarate EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | Teva Pharms USA |
| 30 de mayo de 2017 | ANDA079022 | Atomoxetine ATOMOXETINE HYDROCHLORIDE | Teva Pharms USA |
| 27 de marzo de 2017 | ANDA205300 | Atorvastatin ATORVASTATIN CALCIUM | Teva Pharms USA |
| 27 de enero de 2017 | NDA208799 | Fluticasone propionate and salmeterol AIRDUO DIGIHALER, AIRDUO RESPICLICK | Teva Pharm |
| 22 de noviembre de 2016 | ANDA079141 | Tolterodine tartrate TOLTERODINE TARTRATE | Teva Pharms USA |
| 3 de noviembre de 2016 | ANDA202491 | Olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE | Teva Pharms USA |
| 4 de agosto de 2016 | ANDA204285 | Imatinib mesylate IMATINIB MESYLATE | Teva Pharms USA |
| 9 de marzo de 2016 | ANDA077342 | Sildenafil SILDENAFIL CITRATE | Teva |
| 8 de marzo de 2016 | ANDA204548 | Budesonide BUDESONIDE | Teva Pharms USA |
| 27 de enero de 2016 | ANDA079011 | Fluvastatin FLUVASTATIN SODIUM | Teva Pharms USA |
| 7 de diciembre de 2015 | NDA208194 | Bendamustine hydrochloride BENDEKA | Eagle Pharms |
| 25 de noviembre de 2015 | ANDA090308 | Clozapine CLOZAPINE | Barr Labs Inc |
| 28 de agosto de 2015 | ANDA091059 | Erlotinib ERLOTINIB HYDROCHLORIDE | Teva Pharms USA Inc |
| 7 de julio de 2015 | ANDA078027 | Almotriptan ALMOTRIPTAN MALATE | Teva Pharms USA |
| 23 de febrero de 2015 | ANDA077006 | Tolterodine tartrate TOLTERODINE TARTRATE | Ivax Sub Teva Pharms |
| 22 de abril de 2014 | ANDA091673 | Atazanavir ATAZANAVIR SULFATE | Teva Pharms USA |
| 4 de marzo de 2014 | ANDA078193 | Raloxifene hydrochloride RALOXIFENE HYDROCHLORIDE | Teva Pharms USA |
| 10 de enero de 2014 | ANDA077210 | Pioglitazone PIOGLITAZONE HYDROCHLORIDE | Teva Pharms USA |
| 19 de noviembre de 2013 | ANDA078908 | Dexmethylphenidate hydrochloride DEXMETHYLPHENIDATE HYDROCHLORIDE | Teva Pharms USA |
| 19 de noviembre de 2013 | ANDA202731 | Dexmethylphenidate hydrochloride DEXMETHYLPHENIDATE HYDROCHLORIDE | Teva Pharms USA |
| 10 de octubre de 2013 | ANDA091589 | Tobramycin TOBRAMYCIN | Teva Pharms USA |
| 16 de septiembre de 2013 | ANDA091649 | Capecitabine CAPECITABINE | Teva Pharms USA |
| 26 de abril de 2013 | ANDA090297 | Levalbuterol LEVALBUTEROL HYDROCHLORIDE | Teva Pharms USA |
| 4 de abril de 2013 | ANDA091455 | Acitretin ACITRETIN | Barr Labs Inc |
| 4 de abril de 2013 | ANDA202897 | Acitretin ACITRETIN | Teva Pharms USA |
| 25 de marzo de 2013 | ANDA202074 | Olanzapine and fluoxetine OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | Teva Pharms |
| 31 de diciembre de 2012 | ANDA077263 | Rizatriptan benzoate RIZATRIPTAN BENZOATE | Teva Pharms |
| 28 de septiembre de 2012 | ANDA091661 | Quinine sulfate QUININE SULFATE | Teva Pharms |
| 19 de junio de 2012 | ANDA077528 | Olanzapine and fluoxetine OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | Teva Pharms |
| 12 de junio de 2012 | ANDA078407 | Fluvastatin FLUVASTATIN SODIUM | Teva Pharms |
| 17 de mayo de 2012 | ANDA076999 | Clopidogrel CLOPIDOGREL BISULFATE | Teva |
| 3 de mayo de 2012 | ANDA091347 | Vardenafil VARDENAFIL HYDROCHLORIDE | Teva Pharms |
| 30 de marzo de 2012 | ANDA077369 | Irbesartan and hydrochlorothiazide IRBESARTAN AND HYDROCHLOROTHIAZIDE | Teva |
| 27 de marzo de 2012 | ANDA077745 | Quetiapine QUETIAPINE FUMARATE | Teva Pharms |
| 30 de enero de 2012 | ANDA077243 | Olanzapine OLANZAPINE | Barr Labs Inc |
| 22 de agosto de 2011 | ANDA090199 | Levocetirizine dihydrochloride LEVOCETIRIZINE DIHYDROCHLORIDE | Teva Pharms |
| 3 de junio de 2011 | ANDA090289 | Letrozole LETROZOLE | Teva Pharms |
| 23 de mayo de 2011 | ANDA091169 | Eszopiclone ESZOPICLONE | Teva |
| 28 de junio de 2010 | ANDA076565 | Venlafaxine VENLAFAXINE HYDROCHLORIDE | Teva |
| 28 de junio de 2010 | ANDA078058 | Anastrozole ANASTROZOLE | Teva Pharms |
| 11 de mayo de 2010 | ANDA079193 | Estradiol and norethindrone acetate ESTRADIOL AND NORETHINDRONE ACETATE | Barr |
| 6 de abril de 2010 | ANDA077157 | Losartan potassium and hydrochlorothiazide LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Teva Pharms |
| 25 de marzo de 2010 | NDA022483 | Imiquimod ZYCLARA | Bausch |
| 25 de enero de 2010 | NDA022341 | Liraglutide VICTOZA | Novo Nordisk Inc |
| 10 de noviembre de 2009 | ANDA077255 | Lansoprazole LANSOPRAZOLE | Teva Pharms |
| 6 de noviembre de 2009 | ANDA076221 | Norethindrone acetate and ethinyl estradiol NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL | Barr Labs Inc |
| 6 de mayo de 2009 | ANDA065491 | Mycophenolate mofetil MYCOPHENOLATE MOFETIL | Teva Pharms |
| 18 de noviembre de 2008 | ANDA077519 | Budesonide BUDESONIDE | Teva Pharms |
| 31 de octubre de 2008 | NDA022301 | Mesalamine APRISO | Salix |
| 5 de octubre de 2007 | ANDA077132 | Risedronate RISEDRONATE SODIUM | Teva Pharms USA |
| 5 de septiembre de 2007 | ANDA076373 | Carvedilol CARVEDILOL | Teva |
| 24 de agosto de 2007 | ANDA077487 | Famciclovir FAMCICLOVIR | Teva Pharms |
| 15 de junio de 2007 | NDA021875 | Armodafinil NUVIGIL | Nuvo Pharms |
| 9 de mayo de 2007 | ANDA065368 | Cefdinir CEFDINIR | Teva Pharms |
| 4 de mayo de 2007 | ANDA065332 | Cefdinir CEFDINIR | Teva Pharms |
| 7 de marzo de 2007 | ANDA077750 | Cabergoline CABERGOLINE | Ivax Sub Teva Pharms |
| 1 de febrero de 2007 | NDA021777 | Cyclobenzaprine hydrochloride AMRIX | Teva Pharms Intl |
| 31 de enero de 2007 | NDA021234 | Diclofenac epolamine FLECTOR | Ibsa |
| 3 de agosto de 2006 | ANDA076690 | Venlafaxine VENLAFAXINE HYDROCHLORIDE | Teva |
| 6 de julio de 2006 | ANDA065246 | Azithromycin AZITHROMYCIN | Pliva |
| 5 de julio de 2006 | ANDA040616 | Warfarin sodium WARFARIN SODIUM | Pliva |
| 16 de mayo de 2006 | NDA021641 | Rasagiline AZILECT | Teva |
| 24 de abril de 2006 | ANDA076056 | Pravastatin sodium PRAVASTATIN SODIUM | Aurobindo Pharma USA |
| 20 de enero de 2006 | ANDA065282 | Cefadroxil CEFADROXIL | Teva Pharms |
| 5 de enero de 2006 | ANDA077317 | Isradipine ISRADIPINE | Watson Labs Teva |
| 6 de diciembre de 2005 | ANDA065208 | Cefprozil CEFPROZIL | Teva |
| 14 de noviembre de 2005 | ANDA065218 | Azithromycin AZITHROMYCIN | Pliva |
| 14 de noviembre de 2005 | ANDA065223 | Azithromycin AZITHROMYCIN | Pliva |
| 14 de noviembre de 2005 | ANDA065225 | Azithromycin AZITHROMYCIN | Pliva |
| 28 de octubre de 2005 | ANDA077270 | Glipizide and metformin hydrochloride GLIPIZIDE AND METFORMIN HYDROCHLORIDE | Teva Pharms |
| 10 de agosto de 2005 | ANDA077194 | Clonazepam CLONAZEPAM | Barr |
| 29 de marzo de 2005 | ANDA065110 | Cyclosporine CYCLOSPORINE | Ivax Sub Teva Pharms |
| 25 de marzo de 2005 | ANDA065078 | Cyclosporine CYCLOSPORINE | Ivax Sub Teva Pharms |
| 24 de noviembre de 2004 | ANDA077027 | Cilostazol CILOSTAZOL | Teva |
| 29 de octubre de 2004 | NDA021457 | Albuterol sulfate PROAIR HFA | Teva Branded Pharm |
| 9 de junio de 2004 | ANDA076794 | Ciprofloxacin CIPROFLOXACIN HYDROCHLORIDE | Watson Labs |
| 25 de mayo de 2004 | ANDA065089 | Amoxicillin and clavulanate potassium (amoxicillin / clavulanate) AMOXICILLIN AND CLAVULANATE POTASSIUM | Chartwell Rx |
| 12 de marzo de 2004 | ANDA065162 | Amoxicillin and clavulanate potassium (amoxicillin / clavulanate) AMOXICILLIN AND CLAVULANATE POTASSIUM | Chartwell Rx |
| 29 de diciembre de 2003 | ANDA076392 | Mefloquine hydrochloride MEFLOQUINE HYDROCHLORIDE | Barr |
| 7 de noviembre de 2003 | ANDA065085 | Mupirocin MUPIROCIN | Teva |
| 16 de septiembre de 2003 | ANDA076037 | Nefazodone hydrochloride NEFAZODONE HYDROCHLORIDE | Teva |
| 30 de mayo de 2003 | ANDA076346 | Torsemide TORSEMIDE | Pliva Pharm Ind |
| 30 de mayo de 2003 | ANDA076380 | Norethindrone acetate and ethinyl estradiol JUNEL 1/20 | Barr Labs |
| 30 de mayo de 2003 | ANDA076381 | Norethindrone acetate and ethinyl estradiol JUNEL 1.5/30 | Barr |
| 8 de mayo de 2003 | ANDA076204 | Moexipril hydrochloride MOEXIPRIL HYDROCHLORIDE | Teva |
| 11 de abril de 2003 | ANDA076135 | Isotretinoin CLARAVIS | Teva Pharms USA |
| 11 de abril de 2003 | ANDA076356 | Isotretinoin CLARAVIS | Teva Pharms USA |
| 30 de diciembre de 2002 | NDA021478 | Acyclovir ZOVIRAX | Bausch |
| 4 de diciembre de 2002 | ANDA065119 | Amoxicillin AMOXICILLIN | Chartwell Rx |
| 30 de octubre de 2002 | ANDA065101 | Amoxicillin and clavulanate potassium (amoxicillin / clavulanate) AMOXICILLIN AND CLAVULANATE POTASSIUM | Chartwell Rx |
| 29 de octubre de 2002 | ANDA065096 | Amoxicillin and clavulanate potassium (amoxicillin / clavulanate) AMOXICILLIN AND CLAVULANATE POTASSIUM | Chartwell Rx |
| 4 de septiembre de 2002 | ANDA065058 | Cefaclor CEFACLOR | Teva |
| 19 de junio de 2002 | ANDA075977 | Tramadol hydrochloride TRAMADOL HYDROCHLORIDE | Teva |
| 28 de febrero de 2002 | ANDA075022 | Buspirone BUSPIRONE HYDROCHLORIDE | Teva |
| 11 de febrero de 2002 | ANDA040422 | Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE | Barr |
| 29 de enero de 2002 | ANDA075452 | Fluoxetine FLUOXETINE HYDROCHLORIDE | Teva |
| 29 de enero de 2002 | ANDA076001 | Fluoxetine FLUOXETINE HYDROCHLORIDE | Teva Pharms USA |
| 17 de diciembre de 2001 | ANDA075551 | Lovastatin LOVASTATIN | Teva |
| 12 de octubre de 2001 | ANDA075765 | Calcitriol CALCITRIOL | Teva |
| 25 de mayo de 2001 | ANDA075951 | Norethindrone acetate NORETHINDRONE ACETATE | Barr |
Se muestran las 125 más recientes de 217 solicitudes. Listas completas: Drugs@FDA →
El patrocinador es la empresa titular de la solicitud ante la FDA; puede ser distinta de la etiquetadora.
Cronología de retiros
2026
-
29 de septiembre de 2026 · Clase II · En curso · D-0038-2027 · Metoclopramide
Presence of Foreign Tablets/Capsules
Metoclopramide Tablets, USP, 5 mg, [100 or 500] Tablets per bottle, Rx Only, Manufactured for: Teva Pharmaceuticals, Parsippany, NJ 07054. NDC 100 Tablets: 0093-2204-01; NDC 500 Tablets: 0093-2204-05
-
24 de agosto de 2026 · Clase II · En curso · D-0834-2026 · Trazodone hydrochloride
Presence of Foreign Tablets/Capsules
traZODone Hydrochloride Tablets, USP, 50 mg, Rx only, 100 Tablets, Manufactured in Croatia By: Pliva Hrvatska d.o.o, Zagreb, Croatia, Manufactured For: Teva Pharmaceuticals, Parsippany, NJ 07054, NDC 50111-560-01
-
6 de abril de 2026 · Clase II · En curso · D-0521-2026 · Isotretinoin
Failed Impurities/Degradation Specifications: Out of specification for specific impurity Tretinoin
Claravis (isotretinoin capsule, USP), 10 mg, Packaged as a) 100-count carton, NDC 0555-1054-56, with 10x10 blister packs NDC 0555-1054-60; b) 30-count carton, NDC 0555-1054-86, with 3X10 blister pack NDC 0555-1054-60; Rx
2025
-
7 de octubre de 2025 · Clase II · En curso · D-0104-2026 · Prazosin hydrochloride
CGMP Deviations-Test results for N-nitroso Prazosin impurity C that are above the Carcinogenic Potency Categorization Approach (CPCA) acceptable intake limit for the above specified lots.
Prazosin Hydrochloride, Capsules, USP, 1 mg, Rx only, Distributed by TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, a) 100 Capsules, NDC 0093-4067-01, b) 1000 Capsules, NDC 0093-4067-10
-
7 de octubre de 2025 · Clase II · En curso · D-0106-2026 · Prazosin hydrochloride
CGMP Deviations-Test results for N-nitroso Prazosin impurity C that are above the Carcinogenic Potency Categorization Approach (CPCA) acceptable intake limit for the above specified lots.
Prazosin Hydrochloride, Capsules, USP, 5 mg, Rx only, Distributed by TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, a) 100 Capsules, NDC 0093-4069-01, b) 250 Capsules, NDC 0093-4069-52, c) 500 Capsules, NDC 0093-
-
7 de octubre de 2025 · Clase II · En curso · D-0105-2026 · Prazosin hydrochloride
CGMP Deviations-Test results for N-nitroso Prazosin impurity C that are above the Carcinogenic Potency Categorization Approach (CPCA) acceptable intake limit for the above specified lots.
Prazosin Hydrochloride, Capsules, USP, 2 mg, Rx only, Distributed by TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, a) 100 Capsules, NDC 0093-4068-01, b) 1000 Capsules, NDC 0093-4068-10
-
11 de junio de 2025 · Clase III · En curso · D-0527-2025 · Pitavastatin
Failed Impurities/Degradation Specifications.
Pitavastatin Tablets, 1 mg, Rx Only, 90 Tablets, Manufactured by: Orient Pharma Co., Ltd., 8 Kehu 1st Road, Huwei Chen, Yunlin, Taiwan, 63247, Manufactured for: Teva Pharmaceuticals, Parsippany, NJ 07054, Product of Taiw
-
11 de junio de 2025 · Clase III · En curso · D-0526-2025 · Pitavastatin
Failed Impurities/Degradation Specifications.
Pitavastatin Tablets, 2 mg, Rx Only, 90 Tablets, Manufactured by: Orient Pharma Co., Ltd., 8 Kehu 1st Road, Huwei Chen, Yunlin, Taiwan, 63247, Manufactured for: Teva Pharmaceuticals, Parsippany, NJ 07054, Product of Taiw
-
23 de mayo de 2025 · Clase II · En curso · D-0473-2025 · Metoclopramide
Presence of foreign tablets/capsules.
Metoclopramide Tablets, USP 10 mg, 100-count bottle, Rx only, Manufactured in Croatia by Pliva Hrvatska, d.o.o., Zageb, Croatia, Manufactured for Teva Pharmaceuticals, Parsippany, NJ 07054, NDC 0093-2203-01.
2024
-
25 de enero de 2024 · Clase III · En curso · D-0321-2024 · Norethindrone and ethinyl estradiol
Discoloration: discolored tablets (shades of blue) mixed in with the white inert remainder tablets.
Nortrel (norethindrone and ethinyl estradiol tablets USP) 0.5/35, packaged in cartons, each carton contains 3 blister cards, each card contains 28 tablets, Rx only, TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454,
Mostrar los 49 retiros anteriores
2023
-
5 de julio de 2023 · Clase II · Cerrado por la FDA · D-0913-2023 · Sunitinib malate
Failed Moisture Limits: Water (moisture) content above the approved product specifications.
Sunitinib Malate Capsules, 12.5 mg, 28-count bottles, Rx only, Manufactured By: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, NDC 0093-8199-28
2022
-
29 de agosto de 2022 · Clase II · Cerrado por la FDA · D-1539-2022 · Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate
Labeling: Label Error on Declared Strength; A sealed 100-count bottle labeled with 15 mg actually contained 100 tablets of 20 mg strength of the drug product.
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets (Mixed Salts of a Single Entity Amphetamine Product), 15 mg, Rx Only, 100 tablets per bottle, Teva Pharmaceut
-
23 de agosto de 2022 · Clase II · Cerrado por la FDA · D-1473-2022 · Neomycin sulfate
CGMP Deviations: A foreign matter identified as teflon was found in the Active Pharmaceutical Ingredient (API) used in the manufacture of Neomycin Sulfate Tablets, USP 500 mg.
Neomycin Sulfate Tablets, USP 500 mg , 100-count bottles, Rx only, Distributed by: TEVA PHARMACEUTICALS USA, INC North Wales, PA 19454, NDC 0093-1177-01
-
13 de abril de 2022 · Clase II · Cerrado por la FDA · D-1075-2022 · Mupirocin
cGMP deviations: Temperature abuse
Mupirocin Ointment, USP 2%, 22 grams tube, Rx only, MFG: Teva Pharma USA, NDC 0093-1010-42, MFG: Teva Pharma USA
-
26 de enero de 2022 · Clase II · Cerrado por la FDA · D-0180-2024 · Estradiol
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
ESTRADIOL TABLETS USP, 0.5MG 100 Tablets, Tx Only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454. NDC: 0555-0899-02
-
26 de enero de 2022 · Clase II · Cerrado por la FDA · D-0165-2024 · Amoxicillin
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
AMOXICILLIN for Oral Suspension USP, 400MG/5ML, 100ML (when reconstituted), Manufactured In Canada By: TEVA CANA LIMITED, Toronto, Canada M1B 2K9; Manufactured For: TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454.
-
26 de enero de 2022 · Clase II · Cerrado por la FDA · D-0201-2024 · Warfarin sodium
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Warfarin Sodium Tablets, USP, 5 mg, 100 Tablets per bottle, Rx Only, Manufactured for: Teva Pharmaceuticals, Parsippany, NJ 07054. NDC: 0093-1721-01
-
26 de enero de 2022 · Clase II · Cerrado por la FDA · D-0200-2024 · Warfarin sodium
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Warfarin Sodium Tablets, USP, 2.5 mg, 100 Tablets per bottle, Rx only, Manufactured For: Teva Pharmaceuticals, Parsippany, NJ 07054. NDC: 0093-1714-01
-
7 de enero de 2022 · Clase III · Cerrado por la FDA · D-0522-2022 · Estradiol and norethindrone acetate
Mislabeling
Mimvey (estradiol and norethindrone acetate tablets USP) 1 mg/0.5 mg, packaged in cartons of 28 Tablets, Rx Only, Manufactured By: Barr Laboratories, Inc., Pomona, NY 10970, Manufactured For: Teva Pharmaceuticals USA Inc
-
7 de enero de 2022 · Clase III · Cerrado por la FDA · D-0521-2022 · Estradiol and norethindrone acetate
Mislabeling
Mimvey (estradiol and norethindrone acetate tablets USP), 1 mg/0.5 mg, packaged in cartons of 28 Tablets, Rx only, Manufactured By: Barr Laboratories, Inc., Pomona, NY 10970, Manufactured For: Teva Pharmaceuticals USA In
2021
-
15 de marzo de 2021 · Clase II · Cerrado por la FDA · D-0577-2021 · Epinephrine
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
EPINEPHRINE INJECTION USP, 0.3MG (AUTO-INJECTORS) FOR ALLERGIC EMERGENCIES (ANAPHYLAXIS) 2 Auto-Injectors and 1 Trainer, Manufactured for: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454 NDC 0093-5986-27
-
15 de marzo de 2021 · Clase II · Cerrado por la FDA · D-0574-2021 · Neomycin sulfate
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
NEOMYCIN SULF TABLETS, USP, 500mg, 100-count bottle, Rx Only, Distributed by: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC: 0093-1177-01
-
15 de marzo de 2021 · Clase II · Cerrado por la FDA · D-0578-2021 · Epinephrine
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
EPINEPHRINE INJECTION USP, 0.15 MG (AUTO-INJECTORS) FOR ALLERGIC EMERGENCIES (ANAPHYLAXIS) 2 Auto-Injectors and 1 Trainer, Manufactured for: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454 NDC 0093-5985-27
-
15 de marzo de 2021 · Clase II · Cerrado por la FDA · D-0575-2021 · Bisoprolol fumarate and hydrochlorothiazide
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE TABLETS 2.5 mg/6.25 mg, 100-count bottles, Rx Only, Distributed by: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054 NDC 0093-3241-01 RX; TABLETS
-
15 de marzo de 2021 · Clase II · Cerrado por la FDA · D-0576-2021 · Penicillin v potassium
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
PENICILLIN V POT for Oral Solution, USP 125mg/5mL 100mL (when mixed) Rx Only, Manufactured for: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0093-4125-73
2020
-
4 de septiembre de 2020 · Clase II · Cerrado por la FDA · D-0003-2021 · Buprenorphine
Failed Stability Specifications: Below specification result for buprenorphine release rate.
Buprenorphine Transdermal System 5 mcg/hour, 4 transdermal systems/4 disposal units per carton, Rx Only, Manufactured by: 3M Drug Delivery Systems, 19901 Nordhoff street, Northridge, CA 91324 USA, Manufactured for: Teva
-
24 de agosto de 2020 · Clase II · Cerrado por la FDA · D-1566-2020 · Cephalexin
Sub-Potent Drug: Out of specification test results for potency (below specification).
Cephalexin for Oral Suspension, USP 250 mg per 5 mL, For Reconstitution, For Oral Use Only, Rx Only, 100 mL bottle when mixed, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0093-4177-73.
-
24 de agosto de 2020 · Clase II · Cerrado por la FDA · D-0012-2021 · Cephalexin
CGMP deviations; there is a possibility that some bottles in these lots may have the active ingredient above and/or below specification limits.
Cephalexin for Oral Suspension, USP 125 mg per 5 mL, For Reconstitution, For Oral Use Only, Rx Only, a) 100 mL bottle when mixed, NDC 0093-4175-73, b) 200 mL bottle when mixed, NDC 0093-4175-74, Teva Pharmaceuticals USA,
-
24 de agosto de 2020 · Clase II · Cerrado por la FDA · D-0013-2021 · Cephalexin
CGMP deviations; there is a possibility that some bottles in these lots may have the active ingredient above and/or below specification limits.
Cephalexin for Oral Suspension, USP 250 mg per 5 mL, For Reconstitution, For Oral Use Only, Rx Only, a) 100 mL bottle when mixed, NDC 0093-4177-73, b) 200 mL bottle when mixed, NDC 0093-4177-74, Teva Pharmaceuticals USA,
-
22 de mayo de 2020 · Clase II · Cerrado por la FDA · D-1285-2020 · Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate
Some bottles may contain mixed strengths of the product.
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets ( Mixed Amphetamine Salts Product), 5 mg, 100 count bottles, Rx Only, Teva Pharmaceuticals USA, INC. North Wa
-
22 de mayo de 2020 · Clase II · Cerrado por la FDA · D-1287-2020 · Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate
Some bottles may contain mixed strengths of the product.
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets ( Mixed Amphetamine Salts Product), 20 mg, 100 count bottles, Rx Only, Teva Pharmaceuticals USA, INC. North W
-
22 de mayo de 2020 · Clase II · Cerrado por la FDA · D-1286-2020 · Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate
Some bottles may contain mixed strengths of the product.
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets ( Mixed Amphetamine Salts Product), 15 mg, 100 count bottles, Rx Only, Teva Pharmaceuticals USA, INC. North W
-
5 de marzo de 2020 · Clase II · Cerrado por la FDA · D-1260-2020 · Epinephrine
CGMP Deviations: Precautions taken due to Out-of-specification for trigger force for a non-marketed lot number that shares the same component.
Epinephrine Injection USP, 0.3 mg (Auto-Injector), 0.3 mg/ 0.3 mL pre-filled syringe, Rx Only, Manufactured for Teva Pharmaceuticals USA, Inc. North Wales, PA 19454. NDC 0093-5986-27
2019
-
11 de marzo de 2019 · Clase III · Cerrado por la FDA · D-1006-2019 · Lansoprazole
Subpotent Drug.
Lansoprazole Delayed-Release Orally Disintegrating Tablets, 15 mg, 100 tablets (10 blister cards of 10 tablets each), Rx only, Manufactured in Israel By: Teva Pharmaceutical Ind. Ltd. Jerusalem, 9777402, Israel, Manufact
2018
-
21 de septiembre de 2018 · Clase II · Cerrado por la FDA · D-0001-2019 · Clozapine
Failed Disintegration Specifications: Out-of-specification disintegration test result obtained during routine stability testing.
Clozapine Orally Disintegrating Tablets, 12.5 mg, 100-count bottles, Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0093-5416-01 Yellow, round, flat-faced, beveled-edge, unscored tablet. Debossed wit
-
19 de marzo de 2018 · Clase II · Cerrado por la FDA · D-0620-2018 · Estradiol
Defective Container: This recall is being initiated due to product complaints regarding difficulty in dispensing the tablet from the applicator.
Estradiol Vaginal Inserts, USP 10 mcg, packaged in a) 8 inserts/carton (NDC 0093-3223-08) and b) 18 inserts/carton (NDC 0093-3223-97), Rx only, Teva Women's Health, Inc. Subsidiary of Teva Pharmaceuticals USA, North Wale
2017
-
28 de noviembre de 2017 · Clase III · Cerrado por la FDA · D-0108-2018 · Penicillin v potassium
Failed Impurities/Degradation Specifications: high out of specification test results obtained for individual and total impurities.
Penicillin V Potassium for Oral Solution, USP, 125 mg (200,000 U) per 5 mL, 100 mL (when mixed) bottle, Rx only, Manufactured In Canada By: Teva Canada Limited, Toronto, Canada M1B 2K9; Manufactured For: Teva Pharmaceuti
-
24 de julio de 2017 · Clase II · Cerrado por la FDA · D-1056-2017 · Famotidine
Failed Tablet/Capsule Specification; out of specification for tablet weight
Famotidine Tablets USP, 20 mg, 100 count bottles, Rx only, Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA --- NDC 0172-5728-60
2016
-
24 de junio de 2016 · Clase II · Cerrado por la FDA · D-1470-2016 · Amoxicillin
Superpotent drug: Out of specification test result for assay during stability testing.
Amoxicillin for Oral Suspension USP, 400 mg/ 5 mL, 50 mL bottle, Rx only, Manufactured In Canada by: Teva Canada Limited, Toronto, Canada, NDC 0093-4161-76
2015
-
21 de diciembre de 2015 · Clase II · Cerrado por la FDA · D-0732-2016 · Capecitabine
Failed Dissolution Specifications: low test results at the 18 month time-point
Capecitabine tablets USP 500 mg, Cytotoxic Agent, Rx Only, 120 tablets per bottle, Manufactured in Czech Republic by: Teva Czech Industries sro, Czech Republic, Manufactured for: Teva Pharmaceuticals USA, Sellersville, P
-
12 de noviembre de 2015 · Clase II · Cerrado por la FDA · D-0566-2016 · Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate
Failed Impurities/Degradation Specifications: High out of specification test result for impurities during stability testing.
DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE Tablets (Mixed Salts of a Single Entity Amphetamine Product), 10 mg, 100-count bottle, Rx only, Teva Pharmaceuticals
-
20 de octubre de 2015 · Clase III · Cerrado por la FDA · D-0521-2016 · Irbesartan and hydrochlorothiazide
Labeling: Incorrect or Missing Lot AND/OR Exp Date.
Irbesartan and Hydrochlorothiazide tablets USP 150 mg/ 12.5 mg, 90-count bottles, Rx only, Manufactured in Israel by: TEVA PHARMACEUTICAL INDUSTRIES LTD Jerusalem, 971010 Israel, Manufactured for: TEVA PHARMACEUTICAL IND
-
24 de junio de 2015 · Clase II · Cerrado por la FDA · D-1283-2015 · Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate
Failed Impurities/Degradation Specifications: out of specification for unknown impurity
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, (CII), 10 mg (Mixed Salts of a Single Entity Amphetamine Product), 100 count bottles, manufactured at Barr L
-
13 de abril de 2015 · Clase II · Cerrado por la FDA · D-0971-2015 · Fluoxetine
Chemical Contamination: Product recalled due to an elevated level of a residual solvent impurity in the API that exceeds the Threshold of Toxicological Concern (TTC) calculation for the impurity.
Fluoxetine Capsules USP, 20 mg, packaged in a) 500-count bottles (NDC 50111-648-02), and (b) 1000- count bottles (NDC 50111-648-03), Rx only, Manufactured by Pliva Krakow Pharmaceutical Company S.A., Krakow, Poland; Manu
-
13 de abril de 2015 · Clase II · Cerrado por la FDA · D-0970-2015 · Fluoxetine
Chemical Contamination: Product recalled due to an elevated level of a residual solvent impurity in the API that exceeds the Threshold of Toxicological Concern (TTC) calculation for the impurity.
Fluoxetine Capsules USP, 10 mg, in 100-count bottles, Rx only, Manufactured by Pliva Krakow Pharmaceutical Company S.A., Krakow, Poland, Manufactured for Teva Pharmaceuticals USA, Sellersville, PA 18960. NDC 50111-647-01
2014
-
8 de octubre de 2014 · Clase II · Cerrado por la FDA · D-0050-2015 · Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate
Failed Impurities/Degradation Specifications: Out of specification for unknown impurities.
DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE Tablets, (CII), 10 mg, 100 Tablet Bottles, Rx Only. Teva Pharmaceuticals USA , Sellersville, PA 18960, NDC: 0555-0972
-
29 de mayo de 2014 · Clase II · Cerrado por la FDA · D-1430-2014 · Fluvastatin
Failed Tablet/Capsule Specifications: Teva Pharmaceuticals USA, Inc. is voluntarily recalling one lot of Fluvastatin Capsules USP, 20 mg due to a customer complaint trend regarding capsule breakage.
Fluvastatin Capsules USP, 20 mg, Rx Only, 30-count bottle, manufactured for Teva Pharmaceuticals, Sellersville, PA, by Teva Pharmaceutical IND LTD, Jerusalem, Israel, NDC 0093-7442-56
-
1 de mayo de 2014 · Clase II · Cerrado por la FDA · D-1408-2014 · Dextroamphetamine
Failed Impurities/Degradation Specifications: this product is being recalled due to an out of specification test result for impurities during stability testing.
Dextroamphetamine Sulfate Tablets, USP, 10 mg, 100-count bottles, Rx only, Barr Laboratories, Inc., Pomona, NY 10970, NDC 0555-0953-02.
-
12 de febrero de 2014 · Clase II · Cerrado por la FDA · D-1280-2014 · Fluoxetine
Chemical Contamination: Recall due to a customer complaint trend regarding capsule odor.
Fluoxetine Capsules USP, 20 mg, packaged in a) 100-count bottles (NDC 50111-648-01), b) 500-count bottles (NDC 50111-648-02), c) 1000-count bottles (NDC 50111-648-03), and d) 2000-count bottles (NDC 50111-648-44), Rx onl
-
12 de febrero de 2014 · Clase II · Cerrado por la FDA · D-1281-2014 · Fluoxetine
Chemical Contamination: Recall due to a customer complaint trend regarding capsule odor.
Fluoxetine Capsules USP, 10 mg, 100-count bottles, Rx only, Manufactured in Poland By: Pliva Krakow Pharmaceutical Company S.A., Krakow, Poland; Manufactured For: Teva Pharmaceuticals USA, Sellersville, PA 18960, NDC 501
-
24 de enero de 2014 · Clase II · Cerrado por la FDA · D-1093-2014 · Hydroxyzine
CGMP Deviations: Hydroxyzine Pamoate Capsules, USP, 100 mg were manufactured using an unapproved material: API was incorrectly released for use in manufacturing.
Teva Hydroxyzine Pamoate Capsules, USP, 100 mg, 100- count bottle,Rx only, Distributed by Teva Pharmaceuticals USA, Sellersville, PA. NDC 0555-0324-02
-
24 de enero de 2014 · Clase II · Cerrado por la FDA · D-1095-2014 · Hydroxyzine
CGMP Deviations: Hydroxyzine Pamoate Capsules, USP, 25 mg were manufactured using an unapproved material: API was incorrectly released for use in manufacturing.
Teva Hydroxyzine Pamoate Capsules, USP, 25 mg, 100- count bottle, Rx Only,Distributed by Teva Pharmaceuticals, USA, Sellersville, PA. NDC 0555-0323-02.
-
24 de enero de 2014 · Clase II · Cerrado por la FDA · D-1094-2014 · Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate
CGMP Deviations: Dextroamphetamine Saccharate, Amphetamine Asparate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, CII, 10 mg were manufactured using unapproved material: the finished product was not properly quarantined as rejected due to inadequate cleaning of equipment.
Teva Dextroamphetamine Saccharate, Amphetamine Asparate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, CII, 10 mg (mixed salts) , 100 count-bottle, Rx Only, Distributed by Teva Pharmaceuticals, USA, Sellersv
2013
-
18 de junio de 2013 · Clase III · Cerrado por la FDA · D-803-2013 · Amoxicillin
Discoloration: This recall is being carried out due to an orange to brown discolored Amoxicillin powder on the inner foil seal of the bottles. This is an expansion of RES 65050.
Amoxicillin for Oral Suspension, USP 200 mg/5 mL, a) 75 mL bottle NDC 0093-4160-78 and b) 100 mL bottle NDC 0093-4160-73, Rx Only, Manufactured in Canada by: Teva Canada Limited, Toronto, Canada M1B2K9, Manufactured for:
-
26 de abril de 2013 · Clase III · Cerrado por la FDA · D-598-2013 · Amoxicillin
Discoloration: This recall is being carried out due to a yellow to brown discolored Amoxicillin powder on the inner foil seal of the bottles.
Amoxicillin for Oral Suspension, USP 400mg/5mL, NDC 0093-4161-78 (75ml) and 0093-4161-73 (100mL)
-
15 de marzo de 2013 · Clase III · Cerrado por la FDA · D-682-2013 · Norethindrone acetate and ethinyl estradiol
Failed Impurity/Degradation Specification; an impurity identified as N-Butyl-Benzene Sulfonamide (NBBS) was detected during impurity testing
Junel(TM) Fe 1.5/30 (norethindrone acetate and ethinyl estradiol tablets, USP and ferrous fumarate tablets), 28 day regimen, Rx only, Barr laboratories, Pomona, NY --- NDC 0555-9028-58
-
26 de febrero de 2013 · Clase II · Cerrado por la FDA · D-247-2013 · Cefdinir
Defective Container: This recall is being carried out due to the potential for improperly sealed bottles.
Cefdinir for Oral Suspension, 125 mg/5 mL, packaged in a) 60 mL bottle (NDC 0093-4136-64); b) 100 mL bottle (NDC 0093-4136-73), Rx only, Teva Pharmaceuticals USA, Sellersville, PA 18960.
2012
-
24 de abril de 2012 · Clase III · Cerrado por la FDA · D-128-2013 · Cabergoline
Impurities/Degradation Products: This lot of product will not meet the impurity specification over shelf life
CABERGOLINE Tablets, 0.5 mg, RX only, 8 count bottles, Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960 NDC 0093-5420-88
-
2 de abril de 2012 · Clase II · Cerrado por la FDA · D-1396-2012 · Mefloquine hydrochloride
Tablet Thickness: Product is being recalled due to the potential of being underweight or overweight.
Mefloquine HCL Tablets, 250 mg, 5 tablets per blister pack; 5 Blister packs per carton, Rx only, Teva Pharmaceuticals USA Sellersville, PA 18960, Individual blister pack: NDC 0555-0171-88, 25 Unit-Dose Tablets (5x5) Cart
¿Qué significan las clases de retiro?
Clase I: El tipo más grave: existe una probabilidad razonable de que usar el producto cause problemas de salud graves o la muerte.
Clase II: Usar el producto puede causar problemas de salud temporales o reversibles con tratamiento, o la probabilidad de problemas graves es remota.
Clase III: No es probable que usar el producto cause problemas de salud (por ejemplo, un problema de etiquetado o de envase).
Siguientes pasos
- Encuentre una farmacia cerca de ustedPregunte qué empresa fabricó su medicamento y si tiene un retiro
- Últimos retiros de medicamentos de la FDATodas las empresas, los más recientes primero
- Todas las empresas farmacéuticasDe la A a la Z
- Todos los medicamentos con receta de la A a la ZBusque por nombre genérico, de marca o en español
Fuentes
- NDC Directory (openFDA) — Administración de Alimentos y Medicamentos de los EE. UU. (FDA), datos de la FDA exportados el 13 de noviembre de 2026, consultados el 14 de noviembre de 2026
- Drugs@FDA (openFDA) — Administración de Alimentos y Medicamentos de los EE. UU. (FDA), datos de la FDA exportados el 13 de noviembre de 2026, consultados el 14 de noviembre de 2026
- Drug recall enforcement reports (openFDA) — Administración de Alimentos y Medicamentos de los EE. UU. (FDA), datos de la FDA exportados el 10 de noviembre de 2026, consultados el 14 de noviembre de 2026
Buscador de informes de retiros de la FDA → · Informar un error →